首页> 外文期刊>Biomarkers >Association between red blood cell distribution width and long-term mortality among patients undergoing percutaneous coronary intervention with previous history of cancer
【24h】

Association between red blood cell distribution width and long-term mortality among patients undergoing percutaneous coronary intervention with previous history of cancer

机译:经皮冠状动脉介入术史经皮冠状动脉患者的红细胞分布宽度与长期死亡率之间的关联

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The number of patients suffering from coronary heart disease with cancer is rising. There is scarce evidence concerning the biomarkers related to prognosis among patients undergoing percutaneous coronary intervention (PCI) with cancer. Thus, the aim of this study was to investigate the association between red blood cell distribution width (RDW) and prognosis in this population. Methods: A total of 172 patients undergoing PCI with previous history of cancer were enrolled in this retrospective study. The endpoint was long-term all-cause mortality. According to tertiles of RDW, the patients were classified into three groups: Tertile 1 (RDW 12.8%), Tertile 2 (RDW = 12.8% and 13.5%) and Tertile 3 (RDW = 13.5%). Results: During an average follow-up period of 33.3 months, 29 deaths occurred. Compared with Tertile 3, mortality of Tertile 1 and Tertile 2 was significantly lower in the Kaplan-Meier analysis. In multivariate Cox regression analysis, RDW remained an independent risk factor of mortality (HR: 1.938, 95% CI: 1.295-2.655, p 0.001). The all-cause mortality in Tertile 3 was significantly higher than that in Tertile 1 (HR: 5.766; 95% CI: 1.426-23.310, p = 0.014). Conclusions: An elevated RDW level (= 13.5%) was associated with long-term all-cause mortality among patients undergoing PCI with previous history of cancer.
机译:背景:患有癌症患者患有癌症的患者的数量正在上升。关于患有癌症经皮冠状动脉干预(PCI)的患者的预后的生物标志物有稀缺的证据。因此,本研究的目的是探讨红细胞分布宽度(RDW)与该群体预后之间的关联。方法:在此回顾性研究中注册了患有以前癌症史的PCI的172名患者。终点是长期全导致死亡率。根据RDW的塔,患者分为三组:Tertile1(RDW <12.8%),塔利亚啶2(RDW> = 12.8%和<13.5%)和截1(RDW> = 13.5%)。结果:在33.3个月的平均随访期间,发生了29人死亡。与Tertile 3相比,Kaplan-Meier分析中,Tertile 1和Tertile 2的死亡率显着降低。在多变量Cox回归分析中,RDW仍然是死亡率的独立风险因素(HR:1.938,95%CI:1.295-2.655,P <0.001)。 Tertile 3中的全因死亡率显着高于Tertile1(HR:5.766; 95%CI:1.426-23.310,P = 0.014)。结论:升高的RDW水平(> = 13.5%)与经过以前癌症史进行PCI的患者的长期全因死亡率有关。

著录项

  • 来源
    《Biomarkers》 |2020年第8期|260-267|共8页
  • 作者单位

    Fujian Prov Hosp Fujian Cardiovasc Inst Dept Internal Med Jinshan Branch Fuzhou Peoples R China|Fujian Med Univ Fujian Prov Hosp Clin Med Coll Fuzhou Peoples R China;

    Fujian Med Univ Fujian Prov Hosp Clin Med Coll Fuzhou Peoples R China|Fujian Prov Hosp Fujian Cardiovasc Inst Dept Cardiol Fuzhou Peoples R China;

    Fujian Med Univ Fujian Prov Hosp Clin Med Coll Fuzhou Peoples R China|Fujian Prov Hosp Fujian Cardiovasc Inst Dept Cardiol Fuzhou Peoples R China;

    Fujian Med Univ Fujian Prov Hosp Clin Med Coll Fuzhou Peoples R China|Fujian Prov Hosp Fujian Cardiovasc Inst Dept Cardiol Fuzhou Peoples R China;

    Fujian Med Univ Fujian Prov Hosp Clin Med Coll Fuzhou Peoples R China|Fujian Prov Hosp Fujian Cardiovasc Inst Dept Cardiol Fuzhou Peoples R China;

    Fujian Med Univ Fujian Prov Hosp Clin Med Coll Fuzhou Peoples R China|Fujian Prov Hosp Fujian Cardiovasc Inst Dept Cardiol Fuzhou Peoples R China;

    Fujian Med Univ Fujian Prov Hosp Clin Med Coll Fuzhou Peoples R China|Fujian Prov Hosp Fujian Cardiovasc Inst Dept Cardiol Fuzhou Peoples R China;

    Fujian Med Univ Fujian Prov Hosp Clin Med Coll Fuzhou Peoples R China|Fujian Prov Hosp Fujian Cardiovasc Inst Dept Cardiol Fuzhou Peoples R China;

    Fujian Med Univ Fujian Prov Hosp Clin Med Coll Fuzhou Peoples R China|Fujian Prov Hosp Fujian Cardiovasc Inst Dept Cardiol Fuzhou Peoples R China;

    Fujian Med Univ Fujian Prov Hosp Clin Med Coll Fuzhou Peoples R China|Fujian Prov Hosp Fujian Cardiovasc Inst Dept Cardiol Fuzhou Peoples R China;

    Fujian Med Univ Fujian Prov Hosp Clin Med Coll Fuzhou Peoples R China|Fujian Prov Hosp Fujian Cardiovasc Inst Dept Cardiol Fuzhou Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Biomarker; red blood cell distribution width; mortality; percutaneous coronary intervention; cancer;

    机译:生物标志物;红细胞分布宽度;死亡率;经皮冠状动脉介入;癌症;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号